Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of TITAN Trial.

Soumyajit RoyYilun SunKim N ChiMichael OngShawn MaloneChristopher J D WallisAmar U KishanJulia MaloneUmang SwamiGeorges GebraelJason R BrownAngela Y JiaScott C MorganFred SaadSimon ChowdhuryNeeraj AgarwalDaniel E Spratt

Published in: The Journal of urology (2024)

Early PSA response by 6 months was a predictor of treatment efficacy from ADT plus apalutamide on OS. Longer time to early PSA response was associated with superior OS in the apalutamide arm.

Keyphrases

prostate cancer
radical prostatectomy
small cell lung cancer
clinical trial
study protocol
combination therapy
replacement therapy
phase iii